SPY312.18+4.10 1.33%
DIA263.17+5.32 2.06%
IXIC9,682.91+74.54 0.78%

JP Morgan Downgrades TherapeuticsMD to Neutral

JP Morgan analyst Chris Schott downgrades TherapeuticsMD (NASDAQ:TXMD) from Overweight to Neutral.

Benzinga · 05/19/2020 09:48

JP Morgan analyst Chris Schott downgrades TherapeuticsMD (NASDAQ:TXMD) from Overweight to Neutral.